| PERIOD ENDING | 24-Oct-09 | 25-Jul-09 | 25-Apr-09 | 24-Jan-09 | | Total Revenue | 300,707 | 262,671 | 284,498 | 288,576 | | Cost of Revenue | 205,625 | 182,285 | 193,060 | 209,020 | | | Gross Profit | 95,082 | 80,386 | 91,438 | 79,556 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 84,697 | 77,456 | 87,138 | 94,092 | | Non Recurring | 1,919 | 301 | 901 | 53,754 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 9,865 | 2,629 | 3,399 | (68,290) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 433 | 987 | 595 | 1,014 | | Earnings Before Interest And Taxes | 10,298 | 3,616 | 3,994 | (67,276) | | Interest Expense | 830 | 980 | 1,049 | 1,386 | | Income Before Tax | 9,468 | 2,636 | 2,945 | (68,662) | | Income Tax Expense | 3,762 | 439 | (2,378) | (4,280) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 5,693 | 2,197 | 5,323 | (64,382) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 5,693 | 2,197 | 5,323 | (64,382) | | Preferred Stock And Other Adjustments | 214 | (214) |
-
|
-
| | | Net Income Applicable To Common Shares | $5,907 | $1,983 | $5,323 | ($64,382) |
|
1.52% Nasdaq 0.00%
Income Statement
